New treatment for early-stage lung cancer has Jami Way living the normal life she wants
UCLA Health Connect blog
Post Date:December 19, 2022 9:00 AM
FacultyJane Yanagawa, Amy Cummings
Jami Way recites a mantra out loud before swallowing a pill each morning intended to prevent a return of lung cancer. Way takes Tagrisso, a targeted therapy for non-small cell, early-stage epidermal growth factor receptor (EGFR)-positive lung cancer, where a mutation in the tumor causes cancer to spread quickly.
UCLA Health participated in a global clinical trial that led to expanded use of the drug in 2020, the year Way was diagnosed. Early data showing a big reduction in the risk of recurrence or death among people who underwent surgical removal of their tumors led to expedited approval from the U.S. Food and Drug Administration.
Click here to read the UCLA Healtn Connect blog.